Having financed the group without interruption since its spin-off from the Sanofi group in 1999, EMZ participates in the 4th LBO on the group. The Management of Ceva, majority shareholder of the group, reorganised its capital structure while retaining the control of the group. The new capital structure paves the way to the entry of Temasek, Singaporean sovereign fund and…
WeAreBlow06/30/2014